Discover trends, market shifts, and competitive outlooks for the tumor embolization devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Tumor Embolization Devices Market Size from 2025 to 2034?
The market for tumor embolization devices has witnessed robust growth in the recent past. It is projected to expand from $1493.6 billion in 2024 to $1600.57 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.2%. This surge in the historical timeline can be traced back to factors such as minimally invasive procedures, advancements in technology, increasing cancer cases, and an aging demographic.
The market size for tumor embolization devices is projected to witness robust expansion in the upcoming years, reaching a value of $2286.1 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.3%. The anticipated growth over the forecast period is largely due to factors such as personalized medication, combination treatments, image-guided embolization, along with the use of telemedicine and remote consultations. The forecast period is also expected to see significant trends like innovations in embolic agents, advancements in transarterial chemoembolization (tace), embolization used for palliative care, and procedures guided by imaging.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
What are the Fundamental Drivers and Innovations Shaping the Tumor Embolization Devices Market?
The anticipated global increase in cancer cases could potentially fuel the expansion of the tumor embolization devices market in the forecast period. For example, projections from Macmillan Cancer Support, the foremost healthcare charity in the UK, in October 2022, suggested that by 2025, cancer would affect 3.5 million people, by 2030 this would increase to 4 million, and by 2040 reach 5.3 million. As a result, the expected surge in global cancer cases is predicted to stimulate the need for the tumor embolization market in the coming years.
How Is the Tumor Embolization Devices Market Segmented?
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp
Which Regions Are Driving the Next Phase of the Tumor Embolization Devices Market Growth?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Market Trends in the Tumor Embolization Devices Market Over the Coming Years?
Leading businesses in the tumor embolization devices market are introducing innovative products like angiography systems to improve the precision and efficacy of tumor-targeted therapies. Angiography systems are unique imaging machines that allow the visualisation of blood vessels and understanding of blood flow within the human body. To illustrate, Siemens Healthineers, a healthcare company based in Germany, unveiled the Artis Icono Ceiling in June 2022. This ceiling-mounted angiography system is devised to enhance precision in tumor embolization and various other interventional procedures. The Artis Icono Ceiling has the feature of quick 3D data acquisition, able to gather images at the patient’s head in just 2.5 seconds and from lateral angles in 4 seconds. This component decreases motion discrepancies and lowers the demand for contrast media. The Artis Icono Ceiling is created for versatility, making it suitable for multiple specialities, including interventional radiology and cardiology.
View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
How Is the Tumor Embolization Devices Market Defined and What Are Its Core Parameters?
Tumor embolization devices are minimally invasive devices used in the treatment of tumors. These devices are used either to shut down the supply of blood to the tumor or to deliver tumor-killing therapy directly to the tumor.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
